Supervised controlled feeding trials to test the metabolic effects of eTRF independent of body weight changes have shown large improvements in insulin sensitivity and beta cell responsiveness [4] and reduced 24 h glucose levels [27] in overweight individuals at risk of diabetes. This evidence concerns the gene INS and diabetes mellitus.